Algorithm for choosing hypoglycemic agents in patients with a diagnosis of atherosclerotic cardiovascular disease, heart failure or chronic kidney disease

Journal Title: Нирки - Year 2018, Vol 7, Issue 4

Abstract

.

Authors and Affiliations

Keywords

Related Articles

Resistance of bacteria isolated in urinary tract infections to antimicrobial drugs in children

Background. Urinary tract infection (UTI) is one of the main causes of hospitalization of children. One of the main causes of ineffective treatment of UTI in children is the antibiotic resistance of UTI pathogens. The pu...

Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 1. Сlinical study

Background. Renal damage is an almost constant symptom of gout, which determines the prognosis of the dise­ase. Hyperuricemia in gouty nephropathy belongs to independent risk factors for deterioration of the nitrogen and...

The Experience of Combination Phytotherapy in Patients with Urethrolithiasis

In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...

Enzymaturia as a Marker of Renal Dysfunction in Full-Term Newborns with Perinatal Pathology

Objective — to study the condition of glomerular and tubular functions in full-term newborns with perinatal pathology on the basis of detection of activity of enzymes contained in urine. Materials and methods. We have ex...

Renoprotection and its association with eGFR and renal functional reserve

Renoprotection is a system of measures for primarily pharmacological control, contributing to the continued preservation of renal function. When choosing renoprotection tactics, it is necessary to consider not only the e...

Download PDF file
  • EP ID EP421435
  • DOI 10.22141/2307-1257.7.4.2018.148515
  • Views 70
  • Downloads 0

How To Cite

(2018). Algorithm for choosing hypoglycemic agents in patients with a diagnosis of atherosclerotic cardiovascular disease, heart failure or chronic kidney disease. Нирки, 7(4), 269-270. https://europub.co.uk/articles/-A-421435